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Abstract
Background: One way of defining an individual’s heart effort is to calculate the maximum
heart rate to be expected given their age, but the reinnervation seen in patients who have
received heart transplants makes for different calculations from patients who have suffered
heart failure. The purpose of this study is to evaluate heart rate dynamics (rest, peak and
percentage of predicted heart rate for age) in heart transplant patients compared to optimized
beta-blocked heart failure patients during a treadmill cardiopulmonary exercise test.
Methods: Twenty two (81% male, 46 ± 12 years) sedentary heart failure patients and
15 (47% male, 44 ± 13 years) sedentary heart transplant patients performed a treadmill
cardiopulmonary exercise test between 10 am and 3 pm. Heart failure optimization was considered
50 mg/day or more of carvedilol, with a resting heart rate of between 50 and 60 bpm.
Results: Basal heart rate was lower in heart failure patients (58 ± 5 bpm) compared to heart
transplant patients (93 ± 11 bpm; p < 0.0001). Similarly, the peak heart rate (percentage of
the maximum predicted for age) was lower in heart failure patients (60 ± 13%) compared to
heart transplant patients (80 ± 12; p < 0.0001). Maximum respiratory exchange ratio did not
differ between the groups (1.05 ± 0.06 in heart failure patients and 1.11 ± 0.1 in heart
transplant patients; p = 0.08). Moreover, the heart rate reserve between heart failure (49 ± 22)
and heart transplantation (46 ± 16%) was not different (p = 0.644).
Conclusions: No patient reached the maximum heart rate predicted for their age during
a treadmill cardiopulmonary exercise test. The heart rate reserve was similar between groups.
A heart rate increase in heart transplant patients during cardiopulmonary exercise test of
more than 80% of the maximum age-adjusted value should be considered an effort near the
maximum. (Cardiol J 2009; 16, 3: 254–258)
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Introduction
Heart failure is considered the last stage of
heart disease and a significant cause of mortality and
morbidity worldwide [1]. End-stage heart failure,
marked by a lack of response to medical treatment,
disabling symptoms and repeated hospitalizations,
is associated with high morbidity and mortality [2].
Heart transplantation is an acceptable ‘gold stan-
dard’ treatment for selected patients in the termi-
nal stages [3].
Cardiopulmonary exercise testing is a well-
established technique to evaluate peak oxygen con-
sumption in heart transplant patients. Aerobic exer-
cise training is also a well-established non-pharma-
cological way of increasing oxygen consumption in
heart transplant patients. In this population, the
prescription of adequate aerobic effort is crucial to
obtain both an increase in exercise capacity and
a reasonable control of exercise-related risks [4].
The maximum heart rate adjusted for age
(220 – age) is commonly used to characterize a ma-
ximum effort in normal subjects and prescription of
exercise [5]. Although the heart rate dynamics are
known in optimized carvedilol heart failure patients
[6–8], in heart transplant patients the increased
cardiac output is masked by other factors such as
the cardiac denervation that impairs an efficient
control of heart rate and of cardiac output [9]. The
aim of this study is to evaluate heart rate dynamics
(basal, reserve, peak and percentage of the  predic-
ted heart rate for age) in heart transplant patients
compared to optimized beta-blocked heart failure
patients during a treadmill cardiopulmonary exer-
cise test.
Material and methods
Study population
Twenty two (81% male, 19% female) sedenta-
ry heart failure patients (46 ± 12 years old) having
an average left ventricle ejection fraction of 25 ±
± 11% (determined by echocardiography), and
15 (47% male, 53% female) sedentary heart transplant
patients (44 ± 13 years old) were included in the
study. Data was collected between May 2007 and
September 2008. The characteristics of the subjects
studied and their treatments are shown in Tables 1
and 2. All sedentary heart transplant patients were
in a clinically stable condition, 5.4 ± 3.3 years ha-
ving elapsed following transplantation. Endomyo-
cardial biopsy did not show any evidence of tissue
rejection during the entire study. Heart transplant
and heart failure patients with atrial fibrillation,
a pacemaker, non-cardiovascular functional limita-
tions such as osteoarthritis and chronic obstructive
pulmonary disease were excluded from this study.
Heart failure patients whose drug therapy was not
optimized were also excluded. Optimization was con-
sidered to be 50 mg/day or more of carvedilol and
a resting heart rate of between 50 and 60 beats per
minute, maintained for at least three months [10].
This protocol was approved by the Ethical
Committee of our institution. All patients provided
informed consent prior to participation.
Cardiopulmonary exercise test
Patients were asked to refrain from strenuous
physical activity, and from the consumption of sti-
mulants (coffee, tobacco, alcohol) that could influ-
ence heart rate, for 24 hours before the cardiopul-
monary exercise test. The patients’ last meals were
ingested at least two hours before the start of the
test. All subjects underwent the cardiopulmonary
exercise test on a programmable treadmill (Series
2000, Marquette Electronics, Milwaukee, WI, USA)
in a temperature-controlled room (21–23° C) betwe-
en 10 am and 3 pm with a standard 12 lead continu-
ous electrocardiogram monitor (Max 1, Marquette
Electronics). Blood pressure monitoring was per-
formed by the auscultation method. Minute venti-
lation, oxygen uptake, carbon dioxide output and
other cardiopulmonary variables were acquired
breath-by-breath by a computerized system (Vmax
Table 1. Subject results.
Heart Heart p 95% confidence
failure (22) transplantation (15)  interval
Age (years) 46±12 30±6 0.626 –6.681 to 10.923
Peak oxygen consumption [ml/kg/min] 19±6 31±4 0.805 –5.283 to 4.130
Body mass index [kg/m2] 24±3 22±1 0.054 –6.449 to 0.064
Resting heart rate [bpm] 57±3 89±14 < 0.0001 –40.770 to –28.150
Maximum heart rate predicted for age (%) 60±13 80±12 < 0.0001 –27.660 to –10.671
Heart rate reserve [bpm] 49±22 46±16 0.644 –10.000 to 15.973
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229 model, SensorMedics, Yorba Linda, CA, USA).
Resting oxygen consumption and heart rate were
computed as the mean of the final 30 s of the re-
sting period, while peak effort (oxygen consump-
tion) and heart rate were the mean values of the
final 30 s of effort before exhaustion. The respira-
tory exchange ratios were recorded as the avera-
ged samples obtained during each stage of the pro-
tocol in both heart failure and heart transplant pa-
tients (Modified Naughton protocol). A satisfactory
cardiopulmonary exercise test was characterized by
respiratory exchange ratio > 1.05 and symptoms
of maximum effort. Maximum heart rate predicted
for age was calculated by the equation: 220 – age.
Current medication intake
All heart failure patients were receiving a beta-
blocker (carvedilol) associated with ACE inhibitors
(enalapril) or angiotensin II AT1 receptor antago-
nists (losartan). The medication profile of the
heart failure patient group is shown in Table 2.
Patients took beta-blockers, ACE inhibitors, angio-
tensin II AT1 receptor antagonists and isosorbide
5-mononitrate twice a day: one half of the daily dose
in the morning (9 am), the other half at night (9 pm).
Diuretics, digoxin and spironolactone were taken
in the morning (9 am). All heart transplant reci-
pients were receiving immunosuppressive therapy
twice a day, one half of the daily dose in the mor-
ning, the other half at night. Antihypertensive drugs
were normally taken in the morning.
Statistical analysis
The descriptive analysis was presented as the
mean, standard deviation and 95% confidence inte-
rval (CI). The basal heart rate, peak heart rate, per-
centage of the maximum heart rate predicted for
age, heart rate reserve, respiratory exchange ratio,
VO2, slope VE/VCO2 and body mass index for heart
failure and heart transplant patients were normally
distributed. To compare these variables, we used
the unpaired student’s t-test.
Data was analyzed using the Statistical Package
for Social Sciences for Windows, 11.5 (SPSS Inc,
Chicago, IL, USA). Statistical significance was set
at p < 0.05.
Results
All subjects performed a satisfactory cardiopul-
monary exercise test (respiratory exchange ratio
1.05 ± 0.06 in heart failure patients and 1.11 ± 0.1
in heart transplant patients; p = 0.08). The basal
heart rate was lower in optimized beta-blocked
Table 2. Characteristics of the patients.
Number of patients (%);
dose [mg/day]
Etiology: Heart Heart
failure  transplantation
Ischemic 31% 14%
Non ischemic 69% 86%
NYHA class:
I 50% –
II 14% –
III 36% –
LVEF 25±11% –
Current medications:
Diuretics
Furosemide 64%; 52±30 21%; 33±11
Hydrochloro- 48%; 43±24 21%; 26±2
thiazide
ACE inhibitors
Enalapril 64%; 38±6 42%; 16±5
Captopril 20%; 93±37 –
AII (losartan) 16%; 75±29 7%; 50±0
ARB (carvedilol) 100%; 61±30 –
Spironolactone 30%; 25±0 –
Digoxin 40%; 0.25±0 –
Isosorbide 15%; 56±35 –
5-mononitrate
Immunosupre-
ssive drugs:
Corticosteroids – 57%; 4,5±1
(prednisone)
Antiproliferative –
agents
Azathioprine – 21%; 75±35
Mycophenolate – 71%; 744±488
mofetil
TOR inhibitors
Tracolimus – 7%; 8±0
Sirolimus – 7%; 2±0
Calcineurin inhibitors – 71%; 161±57
(Cyclosporine)
Ca (Diltiazem) – 78%; 78±54
Hydrolazin – 14%; 25±0
Clonidim – 28%; 0,1±0,1
Atorvastatin – 7%; 20±0
Ezetimibe – 7%; 10±0
LVEF — left ventricular ejection fraction; AII — angiotensin II AT1
receptor antagonists; ARB — beta-adrenergic receptor blocker;
Ca — calcium channel blocker
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heart failure patients (58 ± 5 bpm) compared to
heart transplant patients (93 ± 11 bpm; p < 0.0001;
Fig. 1), as also seen with peak heart rate (percenta-
ge of maximum heart rate predicted for age; 60 ±
± 13% for heart failure and 80 ± 12 for heart trans-
plantation; p < 0.0001; Fig. 2). No patients reached
the maximum heart rate predicted for their age.
Moreover, heart rate reserve was not different
between the groups (p = 0.644; Fig. 1).
Discussion
The main finding of this study is that no patient
reached the maximum heart rate predicted for
their age. The heart transplantation group reached
80% of the predicted heart rate. Moreover, no diffe-
rence was seen between heart rate reserve between
heart failure and heart transplantation groups.
Heart rate variability has been studied as a non-
invasive tool to assess cardiac autonomic control of
the nervous system, and it is proposed to reflect the
interaction of sympathetic and parasympathetic
activity [11]. The heart rate dynamics in heart trans-
plant patients during the cardiopulmonary exercise
test is unknown. Achievement of age-predicted
values for maximal heart rate during exercise is
often used as a reflection of maximal or near maxi-
mal effort (220 – age) [5]. This method has been
questioned by some authors [12], but is currently
the most commonly-used one worldwide.
In the first year after heart transplantation, the
autonomic nervous system does not normally exert
significant effects at heart rate. Reinnervation oc-
curs independently of the exercise training [13].
It is known that heart transplant patients with
reinnervation have a greater capacity for exercise
than those with denervation [14]. The most prominent
clinical finding observed in heart transplant patients
is the rapid resting heart rate increase. This is usu-
ally 15–25 beats per minute above age and sex-
matched controls [15]. This is due to the sinoatrial
node free from vagal inhibition.
In rehabilitation programs, the use of the Borg
scale is strongly advised for exercise prescription,
instead of heart rate, because reinnervation status
could impair the heart rate increase during exercise.
Despite this, some exercise training protocols with
heart transplant patients are prescribed by the he-
art rate reserve [4]. It is proposed that peak heart
rate is reduced approximately 80% of the normal
and the heart rate reserve from 30–50 beats
Figure 2. Data is presented as the mean ± 95% confi-
dence interval. Mean peak heart rate (percentage of the
maximum heart rate predicted for age).
Figure 1. Resting heart rate, peak heart rate and heart rate reserve in heart failure patients and heart transplant
patients; HR — heart rate
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per minute [16]. Our study, which looked at heart
transplant patients over a period of more than
a year, showed that the heart rate reserve is the
same as optimized carvedilol heart failure patients.
Perhaps the time of heart transplantation (re-
innervation) could explain these different results.
Carvalho et al. [6] showed that optimized carvedilol
heart failure patients had the same heart rate
reserve as healthy subjects. This data leads us to
think that heart rate reserve could be an important
tool to prescribe exercise in heart transplant patients.
In our study, no patient reached the maximum
heart rate predicted for their age during the cardio-
pulmonary exercise test. Our data suggests that the
maximum heart rate predicted for age (220 – age)
should not be used to estimate a maximum effort
in heart transplant patients. Thus, a peak heart rate
of 80% of the maximum heart rate predicted for age
should be considered to characterize and estimate
a near-maximal effort in heart transplant patients
and help with the prescription of exercise. This
equation [80% (220 – age)] has never been evalu-
ated previously.
Limitations of the study
This study is limited by the small and different
number of patients in each group. We evaluated the
heart rate dynamic in heart failure patients with just
one kind of beta-blocker drug (carvedilol). We used
only one method of cardiopulmonary exercise test
(the treadmill). The neurohormones dynamic was
not performed in this study.
Conclusions
In the treadmill cardiopulmonary exercise test,
optimized beta-blocked heart failure patients had
both rest and peak heart rate lower than heart trans-
plant patients. No patient, in either group, reached
the maximum heart rate predicted by their age,
despite the fact that the heart rate reserve was the
same. In heart transplant patients, the maximum
heart rate during cardiopulmonary exercise test
should be set as 80% of 220 – age to characterize
and estimate near-maximal effort during the exer-
cise treadmill test. Based on our results, we pro-
pose a new method of exercise prescription for
heart transplant patients based on the heart rate.
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